Lilly’s Oral GLP-1, Orforglipron, Succeeds in Third Phase 3 Trial, Paving Way for Global Obesity Filings Read more
Johnson & Johnson Invests $2B in New State-of-the-Art Manufacturing Facility in North Carolina Read more